Pub Date : 2023-07-01Epub Date: 2023-11-20DOI: 10.1109/MPULS.2023.3324241
Andres Diaz Lantada, Mette Ebbesen
Emergent technologies are frequently demonized due to the fear of the unknown. The doubts and alarms are more often than not sparked by their own developers, in a secret wish to become the masters of such fears, and thereby increase their control and influence upon laymen. The story is as old as the use of fire by the sorcerers guiding most ancient rituals. Now it seems to be the turn of artificial intelligence (AI), which is being continuously tainted with quasi-apocalyptic shadows, despite its remarkable potentials for supporting highly desirable societal transformations.
{"title":"Artificial Intelligence Aided Ethics in Frontier Research.","authors":"Andres Diaz Lantada, Mette Ebbesen","doi":"10.1109/MPULS.2023.3324241","DOIUrl":"10.1109/MPULS.2023.3324241","url":null,"abstract":"<p><p>Emergent technologies are frequently demonized due to the fear of the unknown. The doubts and alarms are more often than not sparked by their own developers, in a secret wish to become the masters of such fears, and thereby increase their control and influence upon laymen. The story is as old as the use of fire by the sorcerers guiding most ancient rituals. Now it seems to be the turn of artificial intelligence (AI), which is being continuously tainted with quasi-apocalyptic shadows, despite its remarkable potentials for supporting highly desirable societal transformations.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"14 4","pages":"24-28"},"PeriodicalIF":0.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138177599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-14DOI: 10.3329/pulse.v14i1-3.66892
S. Mamun, Ziaul Haque, R. Jahan, Sharif Md, Qazi Tariqul Islam
During air travel, increasing hypoxia with altitude ascent is a potentially serious problem for patients with hypoxemic chronic airway obstruction (CAO). Travel by air is the most popular way of transport nowadays & estimated that each year worldwide, more than 3 billion passengers travel by air & 736 million in the United States alone. For most passengers, even those with respiratory disease, air travel is safe and comfortable. Some patients with COPD &other Chronic Lung diseases may be at risk but, with screening, these patients can be identified and most of them can travel safely with supplemental oxygen. Some patients with chronic lung disease may have mild hypoxemia at sea level but during air travel in a hypobaric hypoxic environment, compensatory pulmonary mechanisms may be inadequate despite normal sea-level oxygen requirements. In addition, compensatory cardiovascular mechanisms may be less effective in some patients who are unable to increase cardiac output. Air travel also presents an increased risk of venous thromboembolism. It's estimated that, almost 1 medical emergency for every 600 flights. Respiratory symptoms accounted for 12% of all these in-air emergencies. Pulse Volume 12-14 2020-2022 p.16-21
{"title":"Assessment of Fitness for Air travel in Patients with Pulmonary Diseases","authors":"S. Mamun, Ziaul Haque, R. Jahan, Sharif Md, Qazi Tariqul Islam","doi":"10.3329/pulse.v14i1-3.66892","DOIUrl":"https://doi.org/10.3329/pulse.v14i1-3.66892","url":null,"abstract":"During air travel, increasing hypoxia with altitude ascent is a potentially serious problem for patients with hypoxemic chronic airway obstruction (CAO). Travel by air is the most popular way of transport nowadays & estimated that each year worldwide, more than 3 billion passengers travel by air & 736 million in the United States alone. For most passengers, even those with respiratory disease, air travel is safe and comfortable. Some patients with COPD &other Chronic Lung diseases may be at risk but, with screening, these patients can be identified and most of them can travel safely with supplemental oxygen. Some patients with chronic lung disease may have mild hypoxemia at sea level but during air travel in a hypobaric hypoxic environment, compensatory pulmonary mechanisms may be inadequate despite normal sea-level oxygen requirements. In addition, compensatory cardiovascular mechanisms may be less effective in some patients who are unable to increase cardiac output. Air travel also presents an increased risk of venous thromboembolism. It's estimated that, almost 1 medical emergency for every 600 flights. Respiratory symptoms accounted for 12% of all these in-air emergencies. \u0000Pulse Volume 12-14 2020-2022 p.16-21","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"2 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78785143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-14DOI: 10.3329/pulse.v14i1-3.66831
R. Rahim, A. Hasan, Nazmul Hasan, N. Ara, S. Biswas, Mizanur Rahman
Introduction:Influenza is a worldwide respiratory infectious disease which affect all age groups and associated with significant number of morbidity and mortality each year. The circulating subtypes varies countrywide yearly, and it helps policy maker to get preparedness for early effective management of influenza epidemics. Materials and methods Nasal swabs were collected from 463 patients in January and February 2020 presenting flu-like symptoms and Rapid Influenza Diagnostics Tests (RIDTs) were performed for influenza A & B screening as a routine test. Then influenza A subtyping was done by RT-PCR followed by gel electrophoresis of 27 influenza positive samples. Result Among 463 cases, 106 (22.9%) were Influenza positive with huge (99.06%) dominance of Influenza A. Subtyping of randomly selected outpatient derived 27 Influenza A positive cases showed flourishing presence of seasonal Influenza A/H1N1pdm09 (21; 77.8%). Conclusion This small study warrants further elaborate investigation to know circulating influenza A subtyping in the country which may assist health care providers in making treatment decisions and hence, appropriate patient management. Pulse Volume 12-14 2020-2022 p.4-9
{"title":"Dominance of human Influenza H1N1pdm09 in flu like patients during early two months of 2020","authors":"R. Rahim, A. Hasan, Nazmul Hasan, N. Ara, S. Biswas, Mizanur Rahman","doi":"10.3329/pulse.v14i1-3.66831","DOIUrl":"https://doi.org/10.3329/pulse.v14i1-3.66831","url":null,"abstract":"Introduction:Influenza is a worldwide respiratory infectious disease which affect all age groups and associated with significant number of morbidity and mortality each year. The circulating subtypes varies countrywide yearly, and it helps policy maker to get preparedness for early effective management of influenza epidemics. \u0000Materials and methods Nasal swabs were collected from 463 patients in January and February 2020 presenting flu-like symptoms and Rapid Influenza Diagnostics Tests (RIDTs) were performed for influenza A & B screening as a routine test. Then influenza A subtyping was done by RT-PCR followed by gel electrophoresis of 27 influenza positive samples. \u0000Result Among 463 cases, 106 (22.9%) were Influenza positive with huge (99.06%) dominance of Influenza A. Subtyping of randomly selected outpatient derived 27 Influenza A positive cases showed flourishing presence of seasonal Influenza A/H1N1pdm09 (21; 77.8%). \u0000Conclusion This small study warrants further elaborate investigation to know circulating influenza A subtyping in the country which may assist health care providers in making treatment decisions and hence, appropriate patient management. \u0000Pulse Volume 12-14 2020-2022 p.4-9","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"53 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87477726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-14DOI: 10.3329/pulse.v14i1-3.66895
S. Farhana, Taslima Sifat, Shohag Mia, R. Quddus, B. Khan, S. Islam, R. Hussain, MF Kabir
Contrast PET/CT may show layering within the UB, and several examples of have been reported in the literature. But without using contrast this is rare. Our case demonstrates the interesting posterior layering of F18-FDG in urinary bladder in a 78 years old male without the use of contrast. Pulse Volume 12-14 2020-2022 p.32-33
{"title":"An interesting case of Posterior Layering in the Urinary bladder on Fluorine- 18 Fluorodeoxyglucose (F18-FDG) PET-CT study","authors":"S. Farhana, Taslima Sifat, Shohag Mia, R. Quddus, B. Khan, S. Islam, R. Hussain, MF Kabir","doi":"10.3329/pulse.v14i1-3.66895","DOIUrl":"https://doi.org/10.3329/pulse.v14i1-3.66895","url":null,"abstract":"Contrast PET/CT may show layering within the UB, and several examples of have been reported in the literature. But without using contrast this is rare. Our case demonstrates the interesting posterior layering of F18-FDG in urinary bladder in a 78 years old male without the use of contrast. \u0000Pulse Volume 12-14 2020-2022 p.32-33","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"16 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74761115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-14DOI: 10.3329/pulse.v14i1-3.66905
E. Chief
Abstract not available Pulse Volume 12-14 2020-2022 p.60-68
摘要不可用脉冲卷12-14 2020-2022页60-68
{"title":"Pulse Official Vol.12-14","authors":"E. Chief","doi":"10.3329/pulse.v14i1-3.66905","DOIUrl":"https://doi.org/10.3329/pulse.v14i1-3.66905","url":null,"abstract":"Abstract not available \u0000Pulse Volume 12-14 2020-2022 p.60-68","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"59 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83173844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-14DOI: 10.3329/pulse.v14i1-3.66834
A. Khaled, S. Alam
Pineal region tumors constitute about 0.4%-1% of intracranial tumors in adults. These tumors may arise from pineal gland itself or structures around it which are all termed as pineal region tumor. Papillary tumor of the pineal region is a non-parenchymal tumor of the pineal region. First described in 2003, it is an extremely rare tumor. We have presented a case of 27-year-old female patient presented as a pineal tumor. After successful excision, the tumor proved to be Papillary tumor of Pineal region (PTPR) both histomorphologically and immunohistochemical study. Pulse Volume 12-14 2020-2022 p.13-15
{"title":"Papillary Tumor of Pineal Region: A Case Report","authors":"A. Khaled, S. Alam","doi":"10.3329/pulse.v14i1-3.66834","DOIUrl":"https://doi.org/10.3329/pulse.v14i1-3.66834","url":null,"abstract":"Pineal region tumors constitute about 0.4%-1% of intracranial tumors in adults. These tumors may arise from pineal gland itself or structures around it which are all termed as pineal region tumor. Papillary tumor of the pineal region is a non-parenchymal tumor of the pineal region. First described in 2003, it is an extremely rare tumor. We have presented a case of 27-year-old female patient presented as a pineal tumor. After successful excision, the tumor proved to be Papillary tumor of Pineal region (PTPR) both histomorphologically and immunohistochemical study. \u0000Pulse Volume 12-14 2020-2022 p.13-15","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"3 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81875920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-14DOI: 10.3329/pulse.v14i1-3.66898
Nazmul Hasan, R. Rahim, A. Hasan, R. Ali, QM Mahbub Ullah, Mizanur Rahman
Background Sexually Transmitted Infections (STIs) are often diagnosed by clinical symptoms and signs due to lack of sensitive laboratory methods. Most of the time pathogens are not identified and antibiotics are used empirically. The purpose of our study is to find out the STI pathogens detected by sensitive multiplex PCR done routinely in a tertiary care hospital. Materials and methods A total of 578 samples were tested from February 2015 to July 2022. Urine, prostatic secretion, urethral swab, high vaginal swab, semen, throat swabs were collected from symptomatic patients for the routine test. DNA was extracted and Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Trichomonas vaginalis were screened by using CE-IVD approved multiplex Real Time PCR kit. Result Out of 578 cases, 76 (13.15%) were positive for at least one pathogen and 5 were co-infections. Out of 76 positive cases, Chlamydia trachomatis was found 41 (53.9%), Neisseria gonorrhoeae was 13 (17.1%), Mycoplasma genitalium was 12 (15.8%), and Trichomonas vaginalis 5 (6.6%) and co-infections with Neisseria gonorrhoeae and Chlamydia trachomatis was 5 (6.6%). Positivity rate was remarkably higher in male (77.6%) than female (22.4%) and predominant age group was 19-40 years. Conclusion The predominant STIs pathogen found in our cohort is Chlamydia trachomatis followed by Neisseria gonorrhoeae. Multiplex PCR is a wide-ranging diagnostic method for the detection of multiple pathogens simultaneously which allows early and accurate diagnosis of STIs. Pulse Volume 12-14 2020-2022 p.34-39
{"title":"Prevalence of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis among patients suspected of sexually transmitted infections in Evercare Hospital Dhaka during 2015 to 2022","authors":"Nazmul Hasan, R. Rahim, A. Hasan, R. Ali, QM Mahbub Ullah, Mizanur Rahman","doi":"10.3329/pulse.v14i1-3.66898","DOIUrl":"https://doi.org/10.3329/pulse.v14i1-3.66898","url":null,"abstract":"Background Sexually Transmitted Infections (STIs) are often diagnosed by clinical symptoms and signs due to lack of sensitive laboratory methods. Most of the time pathogens are not identified and antibiotics are used empirically. The purpose of our study is to find out the STI pathogens detected by sensitive multiplex PCR done routinely in a tertiary care hospital. \u0000Materials and methods A total of 578 samples were tested from February 2015 to July 2022. Urine, prostatic secretion, urethral swab, high vaginal swab, semen, throat swabs were collected from symptomatic patients for the routine test. DNA was extracted and Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Trichomonas vaginalis were screened by using CE-IVD approved multiplex Real Time PCR kit. \u0000Result Out of 578 cases, 76 (13.15%) were positive for at least one pathogen and 5 were co-infections. Out of 76 positive cases, Chlamydia trachomatis was found 41 (53.9%), Neisseria gonorrhoeae was 13 (17.1%), Mycoplasma genitalium was 12 (15.8%), and Trichomonas vaginalis 5 (6.6%) and co-infections with Neisseria gonorrhoeae and Chlamydia trachomatis was 5 (6.6%). Positivity rate was remarkably higher in male (77.6%) than female (22.4%) and predominant age group was 19-40 years. \u0000Conclusion The predominant STIs pathogen found in our cohort is Chlamydia trachomatis followed by Neisseria gonorrhoeae. Multiplex PCR is a wide-ranging diagnostic method for the detection of multiple pathogens simultaneously which allows early and accurate diagnosis of STIs. \u0000Pulse Volume 12-14 2020-2022 p.34-39","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"38 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82711879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-14DOI: 10.3329/pulse.v14i1-3.66900
T. Yasmin, Narendra Kumar, M. Appasamy, S. Ahsan, KM Masud Rana, R. Kumar, A. Joarder, Z. Rahman, B. Bhattacharjee, Taslima Afrin, Arman Reza Chowdhury
Stereotactic radiosurgery (SRS) has been widely used for the treatment of intracranial lesions. We have been doing SRS since March 2019. The unique ability of SRS to deliver higher focused dose to the smaller targets preferably in a single exposure in a convenient manner while sparing adjacent critical structures has made a more widely adopted treatment option. This case series is intended to show our institutional experience and procedural technique adapted for treating intracranial meningioma using SRS by Linear accelerators. We present five cases of intracranial meningioma. Four had Grade I meningioma and one patient with Grade III meningioma. One patient had radiological diagnosis only and treated with SRS. Two patients underwent gross total resection and SRS was prescribed on the event of recurrence. Rest two patients had recurrence/progression after subtotal resection and adjuvant radiation. The dose prescription ranged from 13 to 21Gy in one to three fractions which was determined by tumor volume, location, grade, proximity to critical structures, pre-existing neurologic impairment, previous treatment history, time to progression/relapse and the ideal balance of prescription dosage and expected problems. There were no acute side effects from any of the procedures. All five patients had improvement in clinical symptoms in the immediate post-SRS period. One patient who has two-year post-SRS revealed a significant regression in the size of the tumor. This case series summarizes the fact that SRS for intracranial meningioma is safe and effective treatment strategy when appropriate. Pulse Volume 12-14 2020-2022 p.40-52
{"title":"Case series report of LINAC-based Stereotactic radiosurgery of Intracranial meningioma – an institutional experience","authors":"T. Yasmin, Narendra Kumar, M. Appasamy, S. Ahsan, KM Masud Rana, R. Kumar, A. Joarder, Z. Rahman, B. Bhattacharjee, Taslima Afrin, Arman Reza Chowdhury","doi":"10.3329/pulse.v14i1-3.66900","DOIUrl":"https://doi.org/10.3329/pulse.v14i1-3.66900","url":null,"abstract":"Stereotactic radiosurgery (SRS) has been widely used for the treatment of intracranial lesions. We have been doing SRS since March 2019. The unique ability of SRS to deliver higher focused dose to the smaller targets preferably in a single exposure in a convenient manner while sparing adjacent critical structures has made a more widely adopted treatment option. This case series is intended to show our institutional experience and procedural technique adapted for treating intracranial meningioma using SRS by Linear accelerators. We present five cases of intracranial meningioma. Four had Grade I meningioma and one patient with Grade III meningioma. One patient had radiological diagnosis only and treated with SRS. Two patients underwent gross total resection and SRS was prescribed on the event of recurrence. Rest two patients had recurrence/progression after subtotal resection and adjuvant radiation. The dose prescription ranged from 13 to 21Gy in one to three fractions which was determined by tumor volume, location, grade, proximity to critical structures, pre-existing neurologic impairment, previous treatment history, time to progression/relapse and the ideal balance of prescription dosage and expected problems. There were no acute side effects from any of the procedures. All five patients had improvement in clinical symptoms in the immediate post-SRS period. One patient who has two-year post-SRS revealed a significant regression in the size of the tumor. This case series summarizes the fact that SRS for intracranial meningioma is safe and effective treatment strategy when appropriate. \u0000Pulse Volume 12-14 2020-2022 p.40-52","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"37 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78679469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-14DOI: 10.3329/pulse.v14i1-3.66893
Md Abu Quoreshi Khan
Corona virus causes severe contagious acute respiratory syndrome known as coronavirus disease 2019 (COVID-19). Several initiatives have been taken to tackle so far. One of them, being therapy based biological nano particles “Exosomes”. Administration of exosomes loaded with immunomodulatory cargo in combination with antiviral drugs will be a promising approach. This study deals with the exosomal isolation techniques of the Bruton Tyrosine Kinase (BTK) protein from cells. It represents initial trials to establish a method to isolate exosomes from human B cells. Pulse Volume 12-14 2020-2022 p.22-25
{"title":"Exosomes - A Potential Candidate to Combat Covid-19 and A Future Emerging Nanotechnology with Diverse Perspectives","authors":"Md Abu Quoreshi Khan","doi":"10.3329/pulse.v14i1-3.66893","DOIUrl":"https://doi.org/10.3329/pulse.v14i1-3.66893","url":null,"abstract":"Corona virus causes severe contagious acute respiratory syndrome known as coronavirus disease 2019 (COVID-19). Several initiatives have been taken to tackle so far. One of them, being therapy based biological nano particles “Exosomes”. Administration of exosomes loaded with immunomodulatory cargo in combination with antiviral drugs will be a promising approach. This study deals with the exosomal isolation techniques of the Bruton Tyrosine Kinase (BTK) protein from cells. It represents initial trials to establish a method to isolate exosomes from human B cells. \u0000Pulse Volume 12-14 2020-2022 p.22-25","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"56 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73857881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号